Risk factor
Vulnerable to price shocks
Profitability factor
Very low or no dividends
About
Viemed Healthcare, Inc., through its operating subsidiaries, delivers essential in-home durable medical equipment (DME) and specialized post-acute respiratory healthcare services to patients throughout the United States. The company's core focus is on respiratory disease management, particularly for chronic obstructive pulmonary disease (COPD). This encompasses a range of solutions such as non-invasive ventilation (NIV), percussion vests, and various other therapeutic interventions. They supply both invasive and non-invasive ventilation equipment and related accessories specifically for individuals with COPD. Viemed facilitates access to necessary equipment through leasing and sales. Their offerings include non-invasive and invasive ventilators, positive airway pressure (PAP) machines, percussion vests, oxygen concentrator units, and other vital small respiratory devices. In addition to DME, they also provide patient medical services. Beyond respiratory care, Viemed extends its services to include neuromuscular care and oxygen therapy. They are also a key provider in sleep apnea management, supplying equipment like PAP, automatic continuous positive airway pressure (APAP), and bi-level positive airway pressure (BiPAP) machines. Furthermore, the company conducts convenient in-home sleep apnea testing. Established in 2006, Viemed Healthcare, Inc. maintains its headquarters in Lafayette, Louisiana.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, undervalued on EV/
Target Price
The average target price of VMD is 11 and suggests 5% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sugg